Menstrual Migraine

• CLINICAL_TRIALS research · 2026-04-16
  Clinical Trial Update: A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine [Phase 3]

  Pfizer is conducting a Phase 3 trial to study rimegepant for intermittent prevention of menstrual migraine in women, and the study is curren…

• CLINICAL_TRIALS research · 2026-03-06
  Clinical Trial Update: Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine [Phase 3]

  Phase 3 trial evaluating oral atogepant in adults with menstrual migraine to assess adverse events and changes in disease activity. The stud…

• CLINICAL_TRIALS trial_result · 2026-02-27
  Clinical Trial Update: Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45 [Phase 4]

  A Phase 4 clinical trial is evaluating fremanezumab for migraine in women with menstrual migraine (ages 18-45); the study is currently activ…

• CLINICAL_TRIALS research · 2025-06-17
  Clinical Trial Update: The Efficacy and Safety of Acupuncture for Prophylaxis of Menstrually Related Migraine [NA]

  A clinical trial update describing a study on the efficacy and safety of electroacupuncture for prophylaxis of menstrually related migraine;…

• CLINICAL_TRIALS research · 2024-10-26
  Clinical Trial Update: Fremanezumab for the Prevention of Menstrually-related Migraine Attacks

  ClinicalTrials.gov entry for a study of fremanezumab to prevent menstrually-related migraine attacks; recruiting, sponsored by Insel Gruppe …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-08-14
  Clinical Trial Update: Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072) [Phase 3]

  A Phase 3 trial of a marketed drug for menstrual migraine has completed.

• CLINICAL_TRIALS trial_result · 2021-07-26
  Clinical Trial Update: A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine [Phase 2]

  Phase 2 trial evaluating efficacy and safety of Sepranolone in women with menstrual migraine has completed.

• CLINICAL_TRIALS trial_result · 2018-04-12
  Clinical Trial Update: Frovatriptan and Menstrual Migraine

  A clinical trial evaluating frovatriptan for menstrual migraine has been terminated.

• CLINICAL_TRIALS research · 2017-05-15
  Clinical Trial Update: Intracranial Pressure During Migraine

  This document provides an update on a clinical trial evaluating intracranial pressure in people with migraine, including menstrual migraine.…

• CLINICAL_TRIALS research · 2015-10-30
  Clinical Trial Update: Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine [NA]

  This clinical trial update compares acupuncture and acupressure for preventing menstrual migraine, with the trial status listed as UNKNOWN.

• CLINICAL_TRIALS trial_result · 2014-04-09
  Clinical Trial Update: CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet [Phase 4]

  Phase 4 study evaluating biomarkers (CGRP, estrogen, cortisol, VIP, α-amylase, PGE2, PGI2, and β-endorphin) in menstrual migraine patients b…

• CLINICAL_TRIALS trial_result · 2012-11-01
  Clinical Trial Update: An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine [Phase 4]

  This Phase 4 clinical trial update assesses the safety and utility of Treximet (sumatriptan/naproxen) for the treatment of menstrual migrain…

• CLINICAL_TRIALS trial_result · 2011-07-25
  Clinical Trial Update: Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals [NA]

  A completed clinical trial comparing frovatriptan to placebo for the prevention of menstrual migraines during hormone-free intervals.

• CLINICAL_TRIALS trial_result · 2010-02-15
  Clinical Trial Update: Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine [Phase 4]

  A Phase 4 clinical trial evaluating the effectiveness and safety of frovatriptan for the acute treatment of menstrual migraine has completed…